The Bank of New York Mellon Corporation

New York Stock Exchange
Slightly Bullish +15

Bank of New York Mellon Corp Reduces Stock Position in Bruker ...

πŸ“‰ Bank of New York Mellon Corp cut its Bruker stake by 6.6% in Q1, reducing holdings to 780,955 shares worth $28.2 million.

πŸ“ˆ Parallel Advisors LLC significantly increased its position by 121.0% in Q4, now owning 875 shares valued at $41,000.

πŸ“Š Bruker reported Q1 EPS of $0.31, surpassing the consensus estimate of $0.23 with revenue of $823.4 million.

🎯 The company raised its FY 2026 EPS guidance to a range of $2.10-$2.15, matching average analyst expectations.

πŸ’° Bruker paid a quarterly dividend of $0.05 per share on July 7th with an ex-dividend date of June 22nd.

πŸ“‰ Analyst consensus remains 'Hold' with an average price target of $56.79, though Citigroup upgraded the objective to $60.

🏦 Bruker maintains a market capitalization of $9.14 billion and a debt-to-equity ratio of 0.67.

πŸ“ˆ Revenue grew 2.7% year-over-year to $823.4 million, indicating continued top-line growth.

Bullish Signals
  • Bruker Corporation beat analyst estimates for both earnings per share and revenue in the most recent quarter, demonstrating operational strength.
  • The company provided FY 2026 guidance of $2.10-$2.15 EPS, which aligns perfectly with the average analyst expectation of $2.12.
  • Revenue increased by 2.7% compared to the same quarter last year, showing consistent top-line growth.
  • The firm maintains a positive return on equity of 11.60%, indicating efficient use of shareholder capital.
  • Several institutional investors, including Parallel Advisors LLC and Allworth Financial LP, have increased their stakes in the company.
Risk Factors
  • Bank of New York Mellon Corp reduced its stake in Bruker by 6.6% in the first quarter, signaling a lack of confidence from a major institutional holder.
  • The company reported a negative net margin of 0.65%, indicating profitability challenges despite revenue growth.
  • Bruker's dividend payout ratio is -83.33%, reflecting that dividends are being paid out of reserves or cash flow rather than current earnings.
Full Analysis
Bank of New York Mellon Corp reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 6.6% in the first quarter, selling 55,379 shares to hold a remaining position of 780,955 shares valued at $28.2 million. Conversely, several other institutional investors increased their holdings, including Allworth Financial LP which grew its stake by 40.6%, and Parallel Advisors LLC which raised its position by 121.0% in the fourth quarter. Analyst sentiment remains mixed with a consensus 'Hold' rating and an average price target of $56.79, though recent upgrades from Wall Street Zen and Citigroup suggest potential upside. Bruker recently reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, while maintaining a positive return on equity despite a negative net margin. The company provided FY 2026 guidance ranging between $2.10 and $2.15 per share, aligning closely with average analyst expectations of $2.12. Bruker also disclosed a quarterly dividend of $0.05 per share paid on July 7th, though the payout ratio is negative due to recent earnings performance. Financial metrics show a market cap of $9.14 billion and a debt-to-equity ratio of 0.67.